Cargando…

Psychological well‐being of early and continuously treated phenylketonuria patients

BACKGROUND: Despite enormous advances in therapy, phenylketonuria (PKU) remains an incurable, inherited metabolic disease requiring life‐long treatment with potential to negatively impact quality of life and psychological well‐being. Therefore, the aim of this study was to screen early diagnosed and...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Alena Gerlinde, Spieß, Nicole, Ascherl, Rudolf, Arelin, Maria, Rohde, Carmen, Kiess, Wieland, Beblo, Skadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100406/
https://www.ncbi.nlm.nih.gov/pubmed/33977032
http://dx.doi.org/10.1002/jmd2.12202
_version_ 1783688781517291520
author Thiele, Alena Gerlinde
Spieß, Nicole
Ascherl, Rudolf
Arelin, Maria
Rohde, Carmen
Kiess, Wieland
Beblo, Skadi
author_facet Thiele, Alena Gerlinde
Spieß, Nicole
Ascherl, Rudolf
Arelin, Maria
Rohde, Carmen
Kiess, Wieland
Beblo, Skadi
author_sort Thiele, Alena Gerlinde
collection PubMed
description BACKGROUND: Despite enormous advances in therapy, phenylketonuria (PKU) remains an incurable, inherited metabolic disease requiring life‐long treatment with potential to negatively impact quality of life and psychological well‐being. Therefore, the aim of this study was to screen early diagnosed and continuously treated children with PKU on psychological strengths and behavioral difficulties. METHODS: Evaluation of psychological strengths and behavioral difficulties in 49 patients with PKU (23f, 2‐17 years) by Strengths and Difficulties Questionnaire (SDQ; self‐report 11‐17 years and parent‐report 2‐17 years). Comparison to age, sex and BMI‐matched healthy controls (n = 98; 46f). RESULTS: In patients with PKU and healthy controls median SDQ Total Difficulties Score and median scores of subscales were within the normal range in parent‐ and self‐report, irrespective of sex and age group (children 2‐10 years, adolescents 11‐17 years). No influence of long‐term metabolic control in PKU on SDQ could be revealed. The 2‐ to 10‐year‐old boys with PKU showed significantly higher scores in Prosocial Behavior compared to their healthy peers (P = .032). Likewise, adolescent boys with PKU showed fewer Conduct Problems (parent‐report, P = .006). Adolescent girls with PKU rated themselves more often as abnormal in the subscale Emotional Problems compared to their healthy peers (P = .041). This subscale was also responsible for a significantly different Total SDQ Difficulties Score between patients and their parents' report (P = .008). DISCUSSION: SDQ represents a suitable instrument within the care for patients with PKU. Specific aspects, however, require separate consideration and evaluation with respect to this chronic disease. Special attention should be paid on adolescent PKU girls who seem to be at risk to develop emotional problem.
format Online
Article
Text
id pubmed-8100406
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-81004062021-05-10 Psychological well‐being of early and continuously treated phenylketonuria patients Thiele, Alena Gerlinde Spieß, Nicole Ascherl, Rudolf Arelin, Maria Rohde, Carmen Kiess, Wieland Beblo, Skadi JIMD Rep Research Reports BACKGROUND: Despite enormous advances in therapy, phenylketonuria (PKU) remains an incurable, inherited metabolic disease requiring life‐long treatment with potential to negatively impact quality of life and psychological well‐being. Therefore, the aim of this study was to screen early diagnosed and continuously treated children with PKU on psychological strengths and behavioral difficulties. METHODS: Evaluation of psychological strengths and behavioral difficulties in 49 patients with PKU (23f, 2‐17 years) by Strengths and Difficulties Questionnaire (SDQ; self‐report 11‐17 years and parent‐report 2‐17 years). Comparison to age, sex and BMI‐matched healthy controls (n = 98; 46f). RESULTS: In patients with PKU and healthy controls median SDQ Total Difficulties Score and median scores of subscales were within the normal range in parent‐ and self‐report, irrespective of sex and age group (children 2‐10 years, adolescents 11‐17 years). No influence of long‐term metabolic control in PKU on SDQ could be revealed. The 2‐ to 10‐year‐old boys with PKU showed significantly higher scores in Prosocial Behavior compared to their healthy peers (P = .032). Likewise, adolescent boys with PKU showed fewer Conduct Problems (parent‐report, P = .006). Adolescent girls with PKU rated themselves more often as abnormal in the subscale Emotional Problems compared to their healthy peers (P = .041). This subscale was also responsible for a significantly different Total SDQ Difficulties Score between patients and their parents' report (P = .008). DISCUSSION: SDQ represents a suitable instrument within the care for patients with PKU. Specific aspects, however, require separate consideration and evaluation with respect to this chronic disease. Special attention should be paid on adolescent PKU girls who seem to be at risk to develop emotional problem. John Wiley & Sons, Inc. 2021-02-21 /pmc/articles/PMC8100406/ /pubmed/33977032 http://dx.doi.org/10.1002/jmd2.12202 Text en © 2021 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Reports
Thiele, Alena Gerlinde
Spieß, Nicole
Ascherl, Rudolf
Arelin, Maria
Rohde, Carmen
Kiess, Wieland
Beblo, Skadi
Psychological well‐being of early and continuously treated phenylketonuria patients
title Psychological well‐being of early and continuously treated phenylketonuria patients
title_full Psychological well‐being of early and continuously treated phenylketonuria patients
title_fullStr Psychological well‐being of early and continuously treated phenylketonuria patients
title_full_unstemmed Psychological well‐being of early and continuously treated phenylketonuria patients
title_short Psychological well‐being of early and continuously treated phenylketonuria patients
title_sort psychological well‐being of early and continuously treated phenylketonuria patients
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100406/
https://www.ncbi.nlm.nih.gov/pubmed/33977032
http://dx.doi.org/10.1002/jmd2.12202
work_keys_str_mv AT thielealenagerlinde psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients
AT spießnicole psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients
AT ascherlrudolf psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients
AT arelinmaria psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients
AT rohdecarmen psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients
AT kiesswieland psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients
AT bebloskadi psychologicalwellbeingofearlyandcontinuouslytreatedphenylketonuriapatients